...to Present Data Demonstrating That Treatment With LAGEVRIO...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that data evaluating LAGEVRIO™, an investigational oral antiviral COVID-19 medicine, will be presented at t...